Security key
640268108
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR)
CUSIP: 640268108
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, $0.0001 par value
- Shares outstanding
- 29,109,163
- Total 13F shares
- 135,417,464
- Share change
- +22,353,885
- Total reported value
- $167,916,168
- Put/Call ratio
- 169%
- Price per share
- $1.24
- Number of holders
- 132
- Value change
- +$31,189,751
- Number of buys
- 68
- Number of sells
- 57
Report period
Q2 2024
Institutions
132
Top holders
10
NKTR full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
NEKTAR THERAPEUTICS SEC filings
NEKTAR THERAPEUTICS company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640268108
Recent filing periods:
Top shareholders of NKTR - NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP |
3/4/5
13F
|
10%+ Owner · Company |
63%
from 13F
|
18,344,000
|
$32,635,810 | — | 10 May 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
41%
|
12,049,138
|
$11,256,304 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
26%
|
7,569,063
|
$7,070,000 | — | 31 Mar 2024 | |
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
24%
|
6,966,647
|
$6,508,242 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
20%
|
5,878,293
|
$5,491,501 | — | 31 Mar 2024 | |
| Monaco Asset Management SAM |
13F
|
Company |
20%
|
5,831,565
|
$5,447,848 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
16%
|
4,620,681
|
$4,317,000 | — | 31 Mar 2024 | |
| TCG Crossover Management, LLC |
13F
|
Company |
14%
|
4,000,000
|
$3,736,800 | — | 31 Mar 2024 | |
| Stonepine Capital Management, LLC |
13F
|
Company |
12%
|
3,480,409
|
$3,251,398 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
11%
|
3,193,714
|
$2,983,568 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
10%
|
2,984,545
|
$2,788,162 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
8.8%
|
2,548,990
|
$2,381,267 | — | 31 Mar 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
8.5%
|
2,475,954
|
$2,313,036 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
7.7%
|
2,240,342
|
$2,092,927 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
7.2%
|
2,081,940
|
$1,944,948 | — | 31 Mar 2024 | |
| Shay Capital LLC |
13F
|
Company |
7.1%
|
2,079,674
|
$1,942,831 | — | 31 Mar 2024 | |
| Lynx1 Capital Management LP |
13F
|
Company |
7.1%
|
2,068,842
|
$1,932,712 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
7.1%
|
2,053,085
|
$1,918,450 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
6.8%
|
1,989,905
|
$1,859,000 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
6.6%
|
1,911,186
|
$1,785,430 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
5.8%
|
1,687,300
|
$1,576,276 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
5.1%
|
1,471,237
|
$1,368,251 | — | 31 Mar 2024 | |
| Acuitas Investments, LLC |
13F
|
Company |
4.4%
|
1,280,604
|
$1,196,340 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
3.9%
|
1,128,319
|
$1,054,076 | — | 31 Mar 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
3.7%
|
1,069,272
|
$998,914 | — | 31 Mar 2024 | |
| CM Management, LLC |
13F
|
Company |
3.2%
|
939,847
|
$878,005 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
3.2%
|
935,620
|
$874,056 | — | 31 Mar 2024 | |
| Almitas Capital LLC |
13F
|
Company |
3.2%
|
920,225
|
$859,674 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2.4%
|
710,306
|
$663,568 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
2.4%
|
691,826
|
$646,304 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
2%
|
574,049
|
$536,277 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
2%
|
572,975
|
$535,274 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.9%
|
543,762
|
$507,983 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.8%
|
535,800
|
$500,544 | — | 31 Mar 2024 | |
| Invesco Ltd. |
13F
|
Company |
1.8%
|
526,343
|
$491,710 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
430,983
|
$385,256 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
1.3%
|
380,999
|
$355,929 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
359,142
|
$335,510 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
1%
|
299,633
|
$279,917 | — | 31 Mar 2024 | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main |
13F
|
Company |
0.99%
|
288,634
|
$269,641 | — | 31 Mar 2024 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.88%
|
256,385
|
$240,000 | — | 31 Mar 2024 | |
| Marquette Asset Management, LLC |
13F
|
Company |
0.8%
|
232,289
|
$217,005 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.76%
|
220,596
|
$206,080 | — | 31 Mar 2024 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.58%
|
169,749
|
$158,580 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.58%
|
168,800
|
$157,694 | — | 31 Mar 2024 | |
| Jillian B. Thomsen |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
313,497
|
$153,614 | — | 16 Feb 2023 | |
| Gil M. Labrucherie |
3/4/5
|
SVP, COO & CFO |
—
class O/S missing
|
312,905
|
$153,323 | — | 15 May 2022 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.44%
|
127,564
|
$119,170 | — | 31 Mar 2024 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.43%
|
126,009
|
$118,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.43%
|
125,445
|
$117,191 | — | 31 Mar 2024 |
Institutional Holders of NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) as of Q2 2024
As of 30 Jun 2024,
NEKTAR THERAPEUTICS - Common Stock, $0.0001 par value (NKTR) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,417,464 shares.
The largest 10 holders included
Deep Track Capital, LP, BlackRock Inc., VANGUARD GROUP INC, SAMLYN CAPITAL, LLC, EVENTIDE ASSET MANAGEMENT, LLC, CITADEL ADVISORS LLC, PRIMECAP MANAGEMENT CO/CA/, ACADIAN ASSET MANAGEMENT LLC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
132
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
117
Q2 2024 holders
132
Holder diff
15
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.